Trial Profile
Efficacy and safety of Lacosamide in patients with Lennox-Gastaut Syndrome and Epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2014
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy; Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 07 Aug 2014 New trial record